Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS

 Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer Noblejas-López, M.d.M.; Gandullo-Sánchez, L.; Galán-Moya, E.M.; López-Rosa, R.; Tébar-García, D.; Nieto-Jiménez, C.; Gómez-Juárez, M.; Burgos, M.; Pandiella, A.; Ocaña, A. Int. J. Mol....

Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications

JOURNAL ARTICLES, JOURNAL ARTICLES 2023, Nanotheranostics generation, biosensors and tracking studies, NOVEL THERAPEUTIC AGENTS

Fernández-Sainz J, Pacheco-Liñán PJ, Ripoll C, González-Fuentes J, Albaladejo J, Bravo I, Garzón-Ruiz A. Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic ImplicationsMol Pharm. 2023 Mar...

Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2023, NOVEL THERAPEUTIC AGENTS

del Campo-Balguerías A, Parra-Cadenas B, Nieto-Jimenez C, Bravo I, Ripoll C, Poyatos-Racionero E, Gancarski P, Carrillo-Hermosilla F, Alonso-Moreno C, Ocaña A. International Journal of Molecular Sciences 2023; 24(18):13820....

Evaluation of Heteroscorpionate Ligands as Scaffolds for the Generation of Ruthenium(Ii) Metallodrugs in Breast Cancer Therapy

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2024, NOVEL THERAPEUTIC AGENTS

Domínguez-Jurado E, Ripoll C, Lara-Sánchez A, Ocaña A, Vitórica-Yrezábal IJ, Bravo I, Alonso-Moreno C.J Inorg Biochem. 2024...

Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models

NOVEL THERAPEUTIC AGENTS

 Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models V Corrales Sanchez, C Nieto-Jiménez, JA Castro-Osma, F De Andrés, … ACS omega 4 (8),...

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium (II) Para-Cymene Complexes for Clinical Development in Breast Cancer

NOVEL THERAPEUTIC AGENTS

 Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium (II) Para-Cymene Complexes for Clinical Development in Breast Cancer E Domínguez-Jurado, FJ Cimas, JA Castro-Osma, A Juan, … Pharmaceutics 13 (10),...